Dor Breier
Ramat Gan, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCs.
Journal: Molecular therapy. Nucleic acids
Published: January 08, 2026
Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors.
Journal: ACS nano
Published: February 06, 2025
Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticles.
Journal: Nature communications
Published: October 29, 2024
Immunogenic amines on lipid nanoparticles.
Journal: Nature biomedical engineering
Published: October 24, 2024
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer.
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 09, 2024
Lipid Nanoparticles With Fine-Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 28, 2024
Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle delivery.
Journal: Molecular therapy. Nucleic acids
Published: June 27, 2024
Delivery of genetic medicines for muscular dystrophies.
Journal: Cell reports. Medicine
Published: April 02, 2024
The immunostimulatory nature of mRNA lipid nanoparticles.
Journal: Advanced drug delivery reviews
Published: October 25, 2023
Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38-Targeted Lipid Nanoparticles.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 01, 2023
Genome editing in cancer: Challenges and potential opportunities.
Journal: Bioactive materials
Published: June 01, 2022
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs.
Journal: Molecular therapy. Nucleic acids
Published: May 18, 2022
Last Updated: 09/26/2026